Denis Drygin - Mar 1, 2022 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Signature
Christopher Aker, Attorney in Fact
Stock symbol
RGLS
Transactions as of
Mar 1, 2022
Transactions value $
$17,638
Form type
4
Date filed
3/1/2022, 04:58 PM
Previous filing
Feb 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Purchase $17.6K +76.7K +328.93% $0.23 100K Mar 1, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.